Cat
Name
Size
Price
Action
MBS6006336-01
MESDC2 (KIAA0081, MESD, LDLR Chaperone MESD, Mesoderm Development Candidate 2, Mesoderm Development Protein, Renal Carcinoma Antigen NY-REN-61)
0.05 mg
Ask
MBS6006336-02
MESDC2 (KIAA0081, MESD, LDLR Chaperone MESD, Mesoderm Development Candidate 2, Mesoderm Development Protein, Renal Carcinoma Antigen NY-REN-61)
5x 0.05 mg
Ask
MBS6320276-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (AP)
0.2 mL
Ask
MBS6320276-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (AP)
5x 0.2 mL
Ask
MBS6011812-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61)
0.2 mL
Ask
MBS6011812-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61)
5x 0.2 mL
Ask
MBS6320286-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (PE)
0.2 mL
Ask
MBS6320286-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (PE)
5x 0.2 mL
Ask
MBS6320278-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (Biotin)
0.2 mL
Ask
MBS6320278-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (Biotin)
5x 0.2 mL
Ask
MBS6320277-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (APC)
0.2 mL
Ask
MBS6320277-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (APC)
5x 0.2 mL
Ask
MBS6320279-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (FITC)
0.2 mL
Ask
MBS6320279-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (FITC)
5x 0.2 mL
Ask
MBS6320280-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (Azide free) (HRP)
0.2 mL
Ask
MBS6320280-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (Azide free) (HRP)
5x 0.2 mL
Ask
MBS6320281-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 405)
0.1 mL
Ask
MBS6320281-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 405)
5x 0.1 mL
Ask
MBS6320283-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 550)
0.1 mL
Ask
MBS6320283-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 550)
5x 0.1 mL
Ask
MBS6320284-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 650)
0.1 mL
Ask
MBS6320284-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 650)
5x 0.1 mL
Ask
MBS6320282-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 490)
0.1 mL
Ask
MBS6320282-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 490)
5x 0.1 mL
Ask
MBS6320285-01
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 750)
0.1 mL
Ask
MBS6320285-02
MESDC2, CT (MESDC2, KIAA0081, MESD, LDLR chaperone MESD, Mesoderm development candidate 2, Mesoderm development protein, Renal carcinoma antigen NY-REN-61) (MaxLight 750)
5x 0.1 mL
Ask
MBS638068-01
MESDC2, aa34-234, Recombinant, Human (Mesoderm Development Candidate 2, BOCA, KIAA0081, LDLR Chaperone MESD, Mesoderm Development Protein, MESD, Renal Carcinoma Antigen NY-REN-61, UNQ1911/PRO4369)
0.1 mg
Ask
MBS638068-02
MESDC2, aa34-234, Recombinant, Human (Mesoderm Development Candidate 2, BOCA, KIAA0081, LDLR Chaperone MESD, Mesoderm Development Protein, MESD, Renal Carcinoma Antigen NY-REN-61, UNQ1911/PRO4369)
5x 0.1 mg
Ask
MBS6160123-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (PE)
0.1 mL
Ask
MBS6160123-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (PE)
5x 0.1 mL
Ask
MBS6149517-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (FITC)
0.1 mL
Ask
MBS6149517-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (FITC)
5x 0.1 mL
Ask
MBS6133608-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (AP)
0.1 mL
Ask
MBS6133608-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (AP)
5x 0.1 mL
Ask
MBS6144214-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (Biotin)
0.1 mL
Ask
MBS6144214-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (Biotin)
5x 0.1 mL
Ask
MBS6138911-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) APC
0.1 mL
Ask
MBS6138911-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) APC
5x 0.1 mL
Ask
MBS6154820-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (HRP)
0.1 mL
Ask
MBS6154820-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (HRP)
5x 0.1 mL
Ask
MBS6224497-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 650)
0.1 mL
Ask
MBS6224497-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 650)
5x 0.1 mL
Ask
MBS6235172-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 750)
0.1 mL
Ask
MBS6235172-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 750)
5x 0.1 mL
Ask
MBS6192472-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 405)
0.1 mL
Ask
MBS6192472-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 405)
5x 0.1 mL
Ask
MBS6203147-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 490)
0.1 mL
Ask
MBS6203147-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 490)
5x 0.1 mL
Ask
MBS6213822-01
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 550)
0.1 mL
Ask
MBS6213822-02
DSE (Dermatan-sulfate Epimerase, DS Epimerase, Chondroitin-glucuronate 5-epimerase, Squamous Cell Carcinoma Antigen Recognized by T-cells 2, SART2, SART-2) (MaxLight 550)
5x 0.1 mL
Ask
MBS6155887-01
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (HRP)
0.1 mL
Ask
MBS6155887-02
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (HRP)
5x 0.1 mL
Ask
MBS6153486-01
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (HRP)
0.1 mL
Ask
MBS6153486-02
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (HRP)
5x 0.1 mL
Ask
MBS6158701-01
MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (PE)
0.1 mL
Ask
MBS6158701-02
MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (PE)
5x 0.1 mL
Ask
MBS6149362-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (FITC)
0.1 mL
Ask
MBS6149362-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (FITC)
5x 0.1 mL
Ask
MBS6149908-01
ST13 (Hsc70-interacting Protein, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, Suppression of Tumorigenicity 13 Protein, FAM10A1, HIP, SNC6, FLJ27260, MGC129952) (FITC)
0.1 mL
Ask
MBS6149908-02
ST13 (Hsc70-interacting Protein, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, Suppression of Tumorigenicity 13 Protein, FAM10A1, HIP, SNC6, FLJ27260, MGC129952) (FITC)
5x 0.1 mL
Ask
MBS6145281-01
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (Biotin)
0.1 mL
Ask
MBS6145281-02
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (Biotin)
5x 0.1 mL
Ask
MBS6320037-01
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (FITC)
0.2 mL
Ask
MBS6320037-02
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (FITC)
5x 0.2 mL
Ask
MBS6320041-01
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 550)
0.1 mL
Ask
MBS6320041-02
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 550)
5x 0.1 mL
Ask
MBS6320042-01
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 650)
0.1 mL
Ask
MBS6320042-02
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 650)
5x 0.1 mL
Ask
MBS6320047-01
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (Biotin)
0.2 mL
Ask
MBS6320047-02
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (Biotin)
5x 0.2 mL
Ask
MBS6320050-01
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 405)
0.1 mL
Ask
MBS6320050-02
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 405)
5x 0.1 mL
Ask
MBS6320051-01
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 490)
0.1 mL
Ask
MBS6320051-02
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 490)
5x 0.1 mL
Ask
MBS6320052-01
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 550)
0.1 mL
Ask
MBS6320052-02
MED6, ID (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (MaxLight 550)
5x 0.1 mL
Ask
MBS631049-01
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
0.2 mL
Ask
MBS631049-02
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
5x 0.2 mL
Ask
MBS6486234-01
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (FITC)
0.2 mL
Ask
MBS6486234-02
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (FITC)
5x 0.2 mL
Ask
MBS6486237-01
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 490)
0.1 mL
Ask
MBS6486237-02
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 490)
5x 0.1 mL
Ask
MBS6486238-01
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 550)
0.1 mL
Ask
MBS6486238-02
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 550)
5x 0.1 mL
Ask
MBS6486240-01
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 750)
0.1 mL
Ask
MBS6486240-02
MAGED2, CT (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1) (MaxLight 750)
5x 0.1 mL
Ask
MBS6481184-01
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
0.2 mL
Ask
MBS6481184-02
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
5x 0.2 mL
Ask
MBS6481187-01
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
0.2 mL
Ask
MBS6481187-02
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
5x 0.2 mL
Ask
MBS6481191-01
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
0.1 mL
Ask
MBS6481191-02
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
5x 0.1 mL
Ask
MBS6481194-01
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
0.2 mL
Ask
MBS6481194-02
HSC70 Interacting Protein (HIP, AAG2, FAM10A1, FAM10A4, FLJ27260, HOP, HSPABP, HSPABP1, MGC129952, P48, PRO0786, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, SNC6, ST13,
5x 0.2 mL
Ask
MBS648146-01
MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1)
0.1 mg
Ask
MBS648146-02
MAGED2 (Melanoma-associated Antigen D2, MAGE-D2 Antigen, Breast Cancer-associated Gene 1 Protein, BCG-1, 11B6, Hepatocellular Carcinoma-associated Protein JCL-1, BCG1)
5x 0.1 mg
Ask
MBS6292610-01
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (Biotin)
0.2 mL
Ask
MBS6292610-02
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (Biotin)
5x 0.2 mL
Ask
MBS6292611-01
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (FITC)
0.2 mL
Ask
MBS6292611-02
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (FITC)
5x 0.2 mL
Ask
MBS6292616-01
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (MaxLight 650)
0.1 mL
Ask
MBS6292616-02
DNAJA2, NT (DNAJA2, CPR3, HIRIP4, DnaJ homolog subfamily A member 2, Cell cycle progression restoration gene 3 protein, Dnj3, HIRA-interacting protein 4, Renal carcinoma antigen NY-REN-14) (MaxLight 650)
5x 0.1 mL
Ask
MBS6144059-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (Biotin)
0.1 mL
Ask
MBS6144059-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (Biotin)
5x 0.1 mL
Ask
MBS6141574-01
DNAJA2 (CPR3, HIRIP4, DnaJ Homolog Subfamily A Member 2, Cell Cycle Progression Restoration Gene 3 Protein, Dnj3, HIRA-interacting Protein 4, Renal Carcinoma Antigen NY-REN-14) (Biotin)
0.1 mL
Ask
MBS6141574-02
DNAJA2 (CPR3, HIRIP4, DnaJ Homolog Subfamily A Member 2, Cell Cycle Progression Restoration Gene 3 Protein, Dnj3, HIRA-interacting Protein 4, Renal Carcinoma Antigen NY-REN-14) (Biotin)
5x 0.1 mL
Ask
BNUB0936-500
Anti-Thomsen-Friedenreich Antigen / CD176 (Pan Carcinoma Marker)(A78-G/A7)
500 µL
Ask
BNUB1294-500
Anti-Thomsen-Friedenreich Antigen / CD176 (Pan Carcinoma Marker)(A84-A/F10)
500 µL
Ask
BNUM1294-50
Anti-Thomsen-Friedenreich Antigen / CD176 (Pan Carcinoma Marker)(A84-A/F10)
50 µL
Ask
BNUM0936-50
Anti-Thomsen-Friedenreich Antigen / CD176 (Pan Carcinoma Marker)(A78-G/A7)
50 µL
Ask
MBS6220365-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.1 mL
Ask
MBS6220365-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.1 mL
Ask
MBS6214213-01
ST13 (Hsc70-interacting Protein, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, Suppression of Tumorigenicity 13 Protein, FAM10A1, HIP, SNC6, FLJ27260, MGC129952) (MaxLight
0.1 mL
Ask
MBS6214213-02
ST13 (Hsc70-interacting Protein, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, Suppression of Tumorigenicity 13 Protein, FAM10A1, HIP, SNC6, FLJ27260, MGC129952) (MaxLight
5x 0.1 mL
Ask
MBS6211181-01
DNAJA2 (CPR3, HIRIP4, DnaJ Homolog Subfamily A Member 2, Cell Cycle Progression Restoration Gene 3 Protein, Dnj3, HIRA-interacting Protein 4, Renal Carcinoma Antigen NY-REN-14) (MaxLight 550)
0.1 mL
Ask
MBS6211181-02
DNAJA2 (CPR3, HIRIP4, DnaJ Homolog Subfamily A Member 2, Cell Cycle Progression Restoration Gene 3 Protein, Dnj3, HIRA-interacting Protein 4, Renal Carcinoma Antigen NY-REN-14) (MaxLight 550)
5x 0.1 mL
Ask
MBS6209690-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.1 mL
Ask
MBS6209690-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.1 mL
Ask
MBS6202992-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (MaxLight 490)
0.1 mL
Ask
MBS6202992-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (MaxLight 490)
5x 0.1 mL
Ask
MBS6401307-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6401307-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6401316-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6401316-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6121596-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6121596-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6120925-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6120925-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6120926-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6120926-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6368197-01
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (AP)
0.2 mL
Ask
MBS6368197-02
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (AP)
5x 0.2 mL
Ask
MBS6368202-01
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (MaxLight 405)
0.1 mL
Ask
MBS6368202-02
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (MaxLight 405)
5x 0.1 mL
Ask
MBS6368205-01
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (MaxLight 650)
0.1 mL
Ask
MBS6368205-02
ZSCAN21, ID (ZSCAN21, ZFP38, ZNF38, Zinc finger and SCAN domain-containing protein 21, Renal carcinoma antigen NY-REN-21, Zinc finger protein 38 homolog) (MaxLight 650)
5x 0.1 mL
Ask
MBS6357792-01
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, Targeting protein for Xklp2, Differentially expressed in cancerous and non-cancerous lung cells 2, Hepatocellular carcinoma-associated antigen 519, Protein fls353, Restricted expression proliferation-associa
0.2 mL
Ask
MBS6357792-02
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, Targeting protein for Xklp2, Differentially expressed in cancerous and non-cancerous lung cells 2, Hepatocellular carcinoma-associated antigen 519, Protein fls353, Restricted expression proliferation-associa
5x 0.2 mL
Ask
MBS6357798-01
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, Targeting protein for Xklp2, Differentially expressed in cancerous and non-cancerous lung cells 2, Hepatocellular carcinoma-associated antigen 519, Protein fls353, Restricted expression proliferation-associa
0.1 mL
Ask
MBS6357798-02
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, Targeting protein for Xklp2, Differentially expressed in cancerous and non-cancerous lung cells 2, Hepatocellular carcinoma-associated antigen 519, Protein fls353, Restricted expression proliferation-associa
5x 0.1 mL
Ask
MBS6269024-01
Mucin 16 (MUC16, MUC-16, CA125, CA-125, Cancer Antigen 125, FLJ14303, Mucin 16 Cell Surface Associated, Cancer-related Tumor Marker CA125, Ovarian Carcinoma Antigen CA125) (APC)
0.1 mL
Ask
MBS6269024-02
Mucin 16 (MUC16, MUC-16, CA125, CA-125, Cancer Antigen 125, FLJ14303, Mucin 16 Cell Surface Associated, Cancer-related Tumor Marker CA125, Ovarian Carcinoma Antigen CA125) (APC)
5x 0.1 mL
Ask
MBS6263954-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6263954-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6264464-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6264464-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6264978-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6264978-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6261910-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6261910-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6261911-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6261911-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6262931-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6262931-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6262420-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6262420-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6262421-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6262421-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6262422-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6262422-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6263442-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6263442-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6263443-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6263443-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6260891-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6260891-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6260892-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6260892-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6261402-01
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
0.1 mL
Ask
MBS6261402-02
MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass
5x 0.1 mL
Ask
MBS6503180-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6503180-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6503182-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6503182-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6503184-01
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
0.2 mL
Ask
MBS6503184-02
TPX2 (P100, C20orf1, C20orf2, DIL2, HCA519, p100, Protein FLS353, Hepatocellular carcinoma-associated antigen 519, Targeting protein for Xklp2, Restricted expression proliferation associated protein 100, Differentially expressed in cancerous and noncancer
5x 0.2 mL
Ask
MBS6399338-01
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (AP)
0.1 mL
Ask
MBS6399338-02
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (AP)
5x 0.1 mL
Ask
MBS6399342-01
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (HRP)
0.1 mL
Ask
MBS6399342-02
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (HRP)
5x 0.1 mL
Ask
MBS6399348-01
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (PE)
0.1 mL
Ask
MBS6399348-02
ZSCAN21 (Zinc Finger and SCAN Domain-containing Protein 21, Renal Carcinoma Antigen NY-REN-21, Zinc Finger Protein 38 Homolog, ZFP38, Zfp-38, ZNF38, Zipro1) (PE)
5x 0.1 mL
Ask
MBS6392663-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (Biotin)
0.1 mL
Ask
MBS6392663-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (Biotin)
5x 0.1 mL
Ask
MBS6392664-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (FITC)
0.1 mL
Ask
MBS6392664-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (FITC)
5x 0.1 mL
Ask
MBS6392665-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (HRP)
0.1 mL
Ask
MBS6392665-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (HRP)
5x 0.1 mL
Ask
MBS6392666-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (MaxLight 405)
0.1 mL
Ask
MBS6392666-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (MaxLight 405)
5x 0.1 mL
Ask
MBS6392671-01
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (PE)
0.1 mL
Ask
MBS6392671-02
RLIM (RING Finger LIM Domain-binding Protein, R-LIM, E3 Ubiquitin-protein Ligase RLIM, LIM Domain-interacting RING Finger Protein, RING Finger Protein 12, RNF12, Renal Carcinoma Antigen NY-REN-43) (PE)
5x 0.1 mL
Ask
MBS6385214-01
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (AP)
0.1 mL
Ask
MBS6385214-02
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (AP)
5x 0.1 mL
Ask
MBS6385217-01
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (FITC)
0.1 mL
Ask
MBS6385217-02
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (FITC)
5x 0.1 mL
Ask